ID ACSL4_MOUSE Reviewed; 711 AA. AC Q9QUJ7; Q5D071; Q9JHT4; Q9R0H3; DT 27-APR-2001, integrated into UniProtKB/Swiss-Prot. DT 27-JUL-2011, sequence version 2. DT 24-JAN-2024, entry version 188. DE RecName: Full=Long-chain-fatty-acid--CoA ligase 4; DE EC=6.2.1.3 {ECO:0000250|UniProtKB:O35547}; DE AltName: Full=Arachidonate--CoA ligase {ECO:0000250|UniProtKB:O35547}; DE EC=6.2.1.15 {ECO:0000250|UniProtKB:O35547}; DE AltName: Full=Long-chain acyl-CoA synthetase 4; DE Short=LACS 4; DE Short=mACS4; GN Name=Acsl4; Synonyms=Acs4, Facl4; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND SHORT). RX PubMed=10924347; DOI=10.1006/bbrc.2000.3207; RA Cho Y.-Y., Kang M.-J., Ogawa S., Yamashita Y., Fujino T., Yamamoto T.T.; RT "Regulation by adrenocorticotropic hormone and arachidonate of the RT expression of acyl-CoA synthetase 4, an arachidonate-preferring enzyme RT expressed in steroidogenic tissues."; RL Biochem. Biophys. Res. Commun. 274:741-745(2000). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT). RC TISSUE=Embryo; RX PubMed=10828604; DOI=10.1159/000015533; RA Vitelli F., Meloni I., Fineschi S., Favara F., Tiziana Storlazzi C., RA Rocchi M., Renieri A.; RT "Identification and characterization of mouse orthologs of the AMMECR1 and RT FACL4 genes deleted in AMME syndrome: orthology of Xq22.3 and MmuXF1-F3."; RL Cytogenet. Cell Genet. 88:259-263(2000). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG). RC STRAIN=C57BL/6J; TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Brown adipose tissue, Kidney, Liver, Lung, Spleen, and RC Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: Catalyzes the conversion of long-chain fatty acids to their CC active form acyl-CoA for both synthesis of cellular lipids, and CC degradation via beta-oxidation. Preferentially activates arachidonate CC and eicosapentaenoate as substrates. Preferentially activates 8,9-EET > CC 14,15-EET > 5,6-EET > 11,12-EET. Modulates glucose-stimulated insulin CC secretion by regulating the levels of unesterified EETs (By CC similarity). Modulates prostaglandin E2 secretion (By similarity). CC {ECO:0000250|UniProtKB:O35547, ECO:0000250|UniProtKB:O60488}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a long-chain fatty acid + ATP + CoA = a long-chain fatty acyl- CC CoA + AMP + diphosphate; Xref=Rhea:RHEA:15421, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57560, CC ChEBI:CHEBI:83139, ChEBI:CHEBI:456215; EC=6.2.1.3; CC Evidence={ECO:0000250|UniProtKB:O35547}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15422; CC Evidence={ECO:0000250|UniProtKB:O35547}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + ATP + CoA = CC (5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + AMP + diphosphate; CC Xref=Rhea:RHEA:19713, ChEBI:CHEBI:30616, ChEBI:CHEBI:32395, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368, CC ChEBI:CHEBI:456215; EC=6.2.1.15; CC Evidence={ECO:0000250|UniProtKB:O35547}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19714; CC Evidence={ECO:0000250|UniProtKB:O35547}; CC -!- CATALYTIC ACTIVITY: CC Reaction=15-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoate + ATP + CoA = 15- CC hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl-CoA + AMP + diphosphate; CC Xref=Rhea:RHEA:52116, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:57287, ChEBI:CHEBI:78832, ChEBI:CHEBI:136409, CC ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:O35547}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52117; CC Evidence={ECO:0000250|UniProtKB:O35547}; CC -!- CATALYTIC ACTIVITY: CC Reaction=12-hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoate + ATP + CoA = 12- CC hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoyl-CoA + AMP + diphosphate; CC Xref=Rhea:RHEA:52112, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:57287, ChEBI:CHEBI:90718, ChEBI:CHEBI:136408, CC ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:O35547}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52113; CC Evidence={ECO:0000250|UniProtKB:O35547}; CC -!- CATALYTIC ACTIVITY: CC Reaction=5-hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoate + ATP + CoA = 5- CC hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoyl-CoA + AMP + diphosphate; CC Xref=Rhea:RHEA:52108, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:57287, ChEBI:CHEBI:65341, ChEBI:CHEBI:136407, CC ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:O35547}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52109; CC Evidence={ECO:0000250|UniProtKB:O35547}; CC -!- CATALYTIC ACTIVITY: CC Reaction=5,6-epoxy-(8Z,11Z,14Z)-eicosatrienoate + ATP + CoA = 5,6- CC epoxy-(8Z,11Z,14Z)-eicosatrienoyl-CoA + AMP + diphosphate; CC Xref=Rhea:RHEA:52088, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:57287, ChEBI:CHEBI:131992, ChEBI:CHEBI:136351, CC ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:O35547}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52089; CC Evidence={ECO:0000250|UniProtKB:O35547}; CC -!- CATALYTIC ACTIVITY: CC Reaction=14,15-epoxy-(5Z,8Z,11Z)-eicosatrienoate + ATP + CoA = 14,15- CC epoxy-(5Z,8Z,11Z)-eicosatrienoyl-CoA + AMP + diphosphate; CC Xref=Rhea:RHEA:52016, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:57287, ChEBI:CHEBI:84024, ChEBI:CHEBI:136117, CC ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:O35547}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52017; CC Evidence={ECO:0000250|UniProtKB:O35547}; CC -!- CATALYTIC ACTIVITY: CC Reaction=11,12-epoxy-(5Z,8Z,14Z)-eicosatrienoate + ATP + CoA = 11,12- CC epoxy-(5Z,8Z,14Z)-eicosatrienoyl-CoA + AMP + diphosphate; CC Xref=Rhea:RHEA:52012, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:57287, ChEBI:CHEBI:76625, ChEBI:CHEBI:136115, CC ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:O35547}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52013; CC Evidence={ECO:0000250|UniProtKB:O35547}; CC -!- CATALYTIC ACTIVITY: CC Reaction=8,9-epoxy-(5Z,11Z,14Z)-eicosatrienoate + ATP + CoA = 8,9- CC epoxy-(5Z,11Z,14Z)-eicosatrienoyl-CoA + AMP + diphosphate; CC Xref=Rhea:RHEA:52008, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:57287, ChEBI:CHEBI:84025, ChEBI:CHEBI:136107, CC ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:O35547}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52009; CC Evidence={ECO:0000250|UniProtKB:O35547}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + CoA + hexadecanoate = AMP + diphosphate + hexadecanoyl- CC CoA; Xref=Rhea:RHEA:30751, ChEBI:CHEBI:7896, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379, CC ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:O60488}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:30752; CC Evidence={ECO:0000250|UniProtKB:O60488}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(E)-hexadec-2-enoate + ATP + CoA = (2E)-hexadecenoyl-CoA + AMP CC + diphosphate; Xref=Rhea:RHEA:36139, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:61526, CC ChEBI:CHEBI:72745, ChEBI:CHEBI:456215; CC Evidence={ECO:0000250|UniProtKB:O60488}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36140; CC Evidence={ECO:0000250|UniProtKB:O60488}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; CC -!- ACTIVITY REGULATION: Both triacsin C and rosiglitazone inhibit CC arachidonoyl-CoA ligase activity. {ECO:0000250|UniProtKB:O60488}. CC -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000250}; CC Single-pass type III membrane protein {ECO:0000250}. Peroxisome CC membrane {ECO:0000250}; Single-pass type III membrane protein CC {ECO:0000250}. Microsome membrane {ECO:0000250}; Single-pass type III CC membrane protein {ECO:0000250}. Endoplasmic reticulum membrane CC {ECO:0000250|UniProtKB:O60488}; Single-pass type III membrane protein CC {ECO:0000250}. Cell membrane {ECO:0000250|UniProtKB:O60488}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=Long; CC IsoId=Q9QUJ7-1; Sequence=Displayed; CC Name=Short; CC IsoId=Q9QUJ7-2; Sequence=VSP_000239; CC -!- TISSUE SPECIFICITY: Abundant in steroidogenic tissues, also found in CC the kidney, brain and liver. CC -!- INDUCTION: Induced by adrenocorticotropic hormone (ACTH) and suppressed CC by glucocorticoid. CC -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB033887; BAA85931.1; -; mRNA. DR EMBL; AB033886; BAA85930.1; -; mRNA. DR EMBL; AB033885; BAA85929.1; -; mRNA. DR EMBL; AJ243502; CAB95965.1; -; mRNA. DR EMBL; AL731672; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC058663; AAH58663.1; -; mRNA. DR CCDS; CCDS30448.1; -. [Q9QUJ7-1] DR CCDS; CCDS41156.1; -. [Q9QUJ7-2] DR RefSeq; NP_001028772.1; NM_001033600.1. [Q9QUJ7-2] DR RefSeq; NP_062350.3; NM_019477.3. [Q9QUJ7-2] DR RefSeq; NP_997508.1; NM_207625.2. [Q9QUJ7-1] DR RefSeq; XP_011246144.1; XM_011247842.2. [Q9QUJ7-2] DR RefSeq; XP_011246145.1; XM_011247843.2. [Q9QUJ7-2] DR AlphaFoldDB; Q9QUJ7; -. DR SMR; Q9QUJ7; -. DR BioGRID; 206122; 5. DR IntAct; Q9QUJ7; 1. DR STRING; 10090.ENSMUSP00000033634; -. DR iPTMnet; Q9QUJ7; -. DR PhosphoSitePlus; Q9QUJ7; -. DR SwissPalm; Q9QUJ7; -. DR EPD; Q9QUJ7; -. DR MaxQB; Q9QUJ7; -. DR PaxDb; 10090-ENSMUSP00000033634; -. DR ProteomicsDB; 285658; -. [Q9QUJ7-1] DR ProteomicsDB; 285659; -. [Q9QUJ7-2] DR Pumba; Q9QUJ7; -. DR Antibodypedia; 444; 409 antibodies from 37 providers. DR DNASU; 50790; -. DR Ensembl; ENSMUST00000033634.5; ENSMUSP00000033634.5; ENSMUSG00000031278.13. [Q9QUJ7-1] DR Ensembl; ENSMUST00000112903.8; ENSMUSP00000108524.2; ENSMUSG00000031278.13. [Q9QUJ7-2] DR Ensembl; ENSMUST00000112904.8; ENSMUSP00000108525.2; ENSMUSG00000031278.13. [Q9QUJ7-2] DR Ensembl; ENSMUST00000112907.8; ENSMUSP00000108528.2; ENSMUSG00000031278.13. [Q9QUJ7-1] DR GeneID; 50790; -. DR KEGG; mmu:50790; -. DR UCSC; uc009ulu.1; mouse. [Q9QUJ7-1] DR AGR; MGI:1354713; -. DR CTD; 2182; -. DR MGI; MGI:1354713; Acsl4. DR VEuPathDB; HostDB:ENSMUSG00000031278; -. DR eggNOG; KOG1180; Eukaryota. DR GeneTree; ENSGT00940000157427; -. DR HOGENOM; CLU_000022_45_2_1; -. DR InParanoid; Q9QUJ7; -. DR OMA; KIFQWAA; -. DR OrthoDB; 443463at2759; -. DR PhylomeDB; Q9QUJ7; -. DR TreeFam; TF314012; -. DR BRENDA; 6.2.1.3; 3474. DR Reactome; R-MMU-434313; Intracellular metabolism of fatty acids regulates insulin secretion. DR Reactome; R-MMU-75876; Synthesis of very long-chain fatty acyl-CoAs. DR BioGRID-ORCS; 50790; 13 hits in 81 CRISPR screens. DR ChiTaRS; Acsl4; mouse. DR PRO; PR:Q9QUJ7; -. DR Proteomes; UP000000589; Chromosome X. DR RNAct; Q9QUJ7; Protein. DR Bgee; ENSMUSG00000031278; Expressed in adrenal gland and 291 other cell types or tissues. DR ExpressionAtlas; Q9QUJ7; baseline and differential. DR GO; GO:0005737; C:cytoplasm; ISO:MGI. DR GO; GO:0005783; C:endoplasmic reticulum; ISO:MGI. DR GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005811; C:lipid droplet; ISO:MGI. DR GO; GO:0044233; C:mitochondria-associated endoplasmic reticulum membrane; ISO:MGI. DR GO; GO:0031966; C:mitochondrial membrane; ISO:MGI. DR GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005739; C:mitochondrion; IDA:MGI. DR GO; GO:0043025; C:neuronal cell body; ISO:MGI. DR GO; GO:0005778; C:peroxisomal membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005777; C:peroxisome; ISO:MGI. DR GO; GO:0005886; C:plasma membrane; ISO:MGI. DR GO; GO:0047676; F:arachidonate-CoA ligase activity; ISS:UniProtKB. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0004467; F:long-chain fatty acid-CoA ligase activity; IDA:MGI. DR GO; GO:0031957; F:very long-chain fatty acid-CoA ligase activity; ISO:MGI. DR GO; GO:0060996; P:dendritic spine development; ISO:MGI. DR GO; GO:0060136; P:embryonic process involved in female pregnancy; IMP:MGI. DR GO; GO:0006631; P:fatty acid metabolic process; ISO:MGI. DR GO; GO:0015908; P:fatty acid transport; ISO:MGI. DR GO; GO:0008610; P:lipid biosynthetic process; ISO:MGI. DR GO; GO:0006629; P:lipid metabolic process; ISO:MGI. DR GO; GO:0001676; P:long-chain fatty acid metabolic process; ISS:UniProtKB. DR GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; ISO:MGI. DR GO; GO:0035336; P:long-chain fatty-acyl-CoA metabolic process; IBA:GO_Central. DR GO; GO:0032307; P:negative regulation of prostaglandin secretion; ISO:MGI. DR GO; GO:0030182; P:neuron differentiation; IBA:GO_Central. DR GO; GO:0030307; P:positive regulation of cell growth; ISO:MGI. DR GO; GO:0032024; P:positive regulation of insulin secretion; ISS:UniProtKB. DR GO; GO:0019217; P:regulation of fatty acid metabolic process; TAS:MGI. DR GO; GO:0019432; P:triglyceride biosynthetic process; ISO:MGI. DR CDD; cd17639; LC_FACS_euk1; 1. DR Gene3D; 3.30.300.30; -; 1. DR Gene3D; 3.40.50.12780; N-terminal domain of ligase-like; 1. DR InterPro; IPR045851; AMP-bd_C_sf. DR InterPro; IPR020845; AMP-binding_CS. DR InterPro; IPR000873; AMP-dep_Synth/Lig_com. DR InterPro; IPR042099; ANL_N_sf. DR PANTHER; PTHR43272; LONG-CHAIN-FATTY-ACID--COA LIGASE; 1. DR PANTHER; PTHR43272:SF22; LONG-CHAIN-FATTY-ACID--COA LIGASE 4; 1. DR Pfam; PF00501; AMP-binding; 1. DR SUPFAM; SSF56801; Acetyl-CoA synthetase-like; 1. DR PROSITE; PS00455; AMP_BINDING; 1. DR Genevisible; Q9QUJ7; MM. PE 1: Evidence at protein level; KW Alternative splicing; ATP-binding; Cell membrane; Endoplasmic reticulum; KW Fatty acid metabolism; Ligase; Lipid metabolism; Magnesium; Membrane; KW Microsome; Mitochondrion; Mitochondrion outer membrane; Nucleotide-binding; KW Peroxisome; Phosphoprotein; Reference proteome; Signal-anchor; KW Transmembrane; Transmembrane helix. FT CHAIN 1..711 FT /note="Long-chain-fatty-acid--CoA ligase 4" FT /id="PRO_0000193110" FT TRANSMEM 8..28 FT /note="Helical; Signal-anchor for type III membrane FT protein" FT /evidence="ECO:0000255" FT TOPO_DOM 29..711 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT MOD_RES 447 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O60488" FT VAR_SEQ 1..41 FT /note="Missing (in isoform Short)" FT /evidence="ECO:0000303|PubMed:10828604, FT ECO:0000303|PubMed:10924347" FT /id="VSP_000239" FT CONFLICT 288 FT /note="V -> L (in Ref. 1; BAA85929/BAA85930/BAA85931)" FT /evidence="ECO:0000305" FT CONFLICT 293 FT /note="S -> T (in Ref. 1; BAA85929/BAA85930/BAA85931)" FT /evidence="ECO:0000305" FT CONFLICT 430..432 FT /note="ALL -> DLV (in Ref. 1; BAA85929/BAA85930/BAA85931)" FT /evidence="ECO:0000305" FT CONFLICT 441 FT /note="S -> Y (in Ref. 1; BAA85929/BAA85930/BAA85931)" FT /evidence="ECO:0000305" FT CONFLICT 458 FT /note="F -> L (in Ref. 1; BAA85929/BAA85930/BAA85931)" FT /evidence="ECO:0000305" FT CONFLICT 584 FT /note="S -> F (in Ref. 1; BAA85929/BAA85930/BAA85931)" FT /evidence="ECO:0000305" FT CONFLICT 704 FT /note="I -> V (in Ref. 1; BAA85929/BAA85930/BAA85931)" FT /evidence="ECO:0000305" SQ SEQUENCE 711 AA; 79077 MW; 84ACA29CADDD6A3A CRC64; MNLKLNVLTI ILLPVHLLIT IYSALIFIPW YFLTNAKKKN AMAKRIKAKP TSDKPGSPYR SVTHFDSLAV IDIPGADTLD KLFDHAVAKF GKKDSLGTRE ILSEENEMQP NGKVFKKLIL GNYKWINYLE VNCRVNNFGS GLTALGLKPK NTIAIFCETR AEWMIAAQTC FKYNFPLVTL YATLGREAVV HGLNESEASY LITSVELLES KLKAALVDIN CVKHIIYVDN KTINRAEYPE GLEIHSMQSV EELGAKPENL SVPPSRPTPS DMAIVMYTSG STGRPKGVMM HHSNLIAGMT GQCERIPGLG PKDTYIGYLP LAHVLELTAE ISCFTYGCRI GYSSPLTLSD QSSKIKKGSK GDCTVLKPTL MAAVPEIMDR IYKNVMSKVQ EMNYVQKTLF KIGYDYKLEQ IKKGYDAPLC NLILFKKVKA LLGGNVRMML SGGAPLSPQT HRFMNVCFCC PIGQGYGLTE SCGAGTVTEV TDYTTGRVGA PLICCEIKLK DWQEGGYTVH DKPNPRGEIV IGGQNISMGY FKNEEKTAED YCVDENGQRW FCTGDIGEFH PDGCLQIIDR KKDLVKLQAG EYVSLGKVEA ALKNCPLIDN ICAFAKSDQS YVISFVVPNQ KKLTLLAQQK GVEGSWVDIC NNPAMEAEIL KEIREAANAM KLERFEIPIK VRLSPEPWTP ETGLVTDAFK LKRKELKNHY LKDIERMYGG K //